-
ATNM Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Actinium Pharmaceuticals (ATNM)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 78.98 mm | 78.98 mm | 78.98 mm | 78.98 mm | 78.98 mm | 78.98 mm |
Cash burn (monthly) | 2.46 mm | 358.83 k | 4.20 mm | 3.75 mm | 3.99 mm | 2.90 mm |
Cash used (since last report) | 12.49 mm | 1.82 mm | 21.34 mm | 19.04 mm | 20.28 mm | 14.74 mm |
Cash remaining | 66.49 mm | 77.16 mm | 57.64 mm | 59.94 mm | 58.70 mm | 64.24 mm |
Runway (months of cash) | 27.1 | 215.0 | 13.7 | 16.0 | 14.7 | 22.1 |
13F holders | Current |
---|---|
Total holders | 71 |
Opened positions | 13 |
Closed positions | 17 |
Increased positions | 27 |
Reduced positions | 14 |
13F shares | Current |
---|---|
Total value | 9.51 bn |
Total shares | 9.61 mm |
Total puts | 4.80 k |
Total calls | 59.62 k |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 1.97 mm | $2.48 bn |
Vanguard | 1.62 mm | $2.04 bn |
Bigger Capital | 769.45 k | $1.37 mm |
Bigger Capital Fund L P | 708.17 k | $0.00 |
Geode Capital Management | 687.85 k | $866.84 mm |
STT State Street | 621.08 k | $782.56 mm |
Acadian Asset Management | 499.26 k | $628.00 k |
NTRS Northern Trust | 251.93 k | $317.43 mm |
MS Morgan Stanley | 216.13 k | $272.33 mm |
Los Angeles Capital Management & Equity Research | 213.95 k | $269.58 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Nov 24 | June Sherie Almenoff | Stock Option Common Stock | Grant | Acquire A | No | No | 1.71 | 50,000 | 85.50 k | 50,000 |
28 Dec 23 | C. David Nicholson, | Stock Option Common Stock | Grant | Acquire A | No | No | 5 | 70,311 | 351.56 k | 70,311 |
28 Dec 23 | Jeffrey W. Chell | Stock Option Common Stock | Grant | Acquire A | No | No | 5 | 70,311 | 351.56 k | 70,311 |
28 Dec 23 | Steve O'Loughlin | Stock Option Common Stock | Grant | Acquire A | No | No | 5 | 253,123 | 1.27 mm | 253,123 |